JULY 2015 HIV – HCV – TB PIPELINE REPORT
Drugs, Diagnostic, Vaccines, Preventive Technologies, etc. 183 págs.
By Polly Clayden, Simon Collins, Mike Frick, Mark Harrington, Tim Horn, Richard Jefferys, Erica Lessem, Lindsay McKenna, and Tracy Swan
HIV i-BASE/TREATMENT ACTION GROUP
HIV i-Base is a London-based HIV treatment activist organization.
HIV i-Base works in the United Kingdom and internationally to ensure that people living with HIV are actively engaged in their own treatment and medical care and are included in policy discussions about HIV treatment recommendations and access.
TABLE of CONTENTS
The Antiretroviral Pipeline 1
Fit for Purpose: Treatment Optimization 25
The Pediatric Antiretroviral Pipeline 41
Preventive Technologies: Antiretroviral and Vaccine Development 57
Research Toward a Cure and Immune-Based and Gene Therapies 81
New Drugs, New Strategies: Conquering Hepatitis C with Direct-Acting Antivirals 103
The Tuberculosis Treatment Pipeline: Moving Beyond “Making the Most of What We’ve Got” 121
Momentum in the Pediatric Tuberculosis Treatment Pipeline 137
The Tuberculosis Diagnostics Pipeline 153
The Tuberculosis Vaccines Pipeline: A New Path to the Same Destination? 163
Entry filed under: Antirretrovirales, Antivirales no HIV, Biología Molecular, Hepatitis C, HIV/SIDA, HIV/SIDA HAART, Infecciones respiratorias, Infecciones virales, Inmunizaciones, Metodos diagnosticos, Micobacterias, REPORTS. Tags: .